Plane of nutrition during gestation affects reproductive performance and retention rate of hyperprolific sows under commercial conditions.

Defining a maternal plane of nutrition during gestation is pivotal for improving sow productivity and the cost-effectiveness of feeding. The benefits of increasing the amount of feed during late gestation have been controversial. The objective of this study was to investigate the effects of different planes of nutrition during gestation on reproductive performance of hyperprolific sows and pre-weaning litter performance. One hundred and thirty-five gestating sows were randomly assigned to one of three planes of nutrition throughout parities three and four (P4), as follows: Req - plane designed to meet requirements of prolific sows (2.3 kg per day from day 1 to 21; 1.8 kg per day from day 22 to 75; 2.3 kg per day from day 76 to farrowing); Bump - plane designed as the Req, with increased feed intake during late gestation (3.0 kg per day from day 91 to farrowing); and Maintenance - plane designed to closely meet maintenance requirements of sows (1.8 kg per day from day 1 to farrowing). All treatments were fed the same gestation diet (2.50MCal NE/kg; 0.67% SID Lysine; 15.17% CP). Sow biometrical parameters at farrowing and at weaning, and litter characteristics were recorded. Also, blood samples were collected for pre- and post-prandial serum glucose and plasma insulin, as well as triglycerides, calcium, and phosphorus analyses. Culling, stratified by cause, and retention rates were recorded in all treatments for each parity. Over two parities, Bump sows had higher weight gain and, at P4, had a higher number of piglets born alive (P < 0.05). Bump sows lost more weight between the end of gestation and weaning over two parities (P < 0.05). Maintenance sows showed reduced body condition score with a higher percentage of piglets removed throughout lactation (due to inappetence and inability to reach the udder) at P4 (P = 0.03). Pre- and post-prandial glucose levels were higher in Bump sows, as well as post-prandial insulin and phosphorus levels at P4 (P < 0.05). Bump sows also showed increased plasma triglycerides compared to the other treatments (P = 0.03). Retention rate was reduced in Maintenance compared to Bump and Req sows at parity 5 (P = 0.02). Taken together, our results indicate that higher feed intake allowance during late gestation may improve the sow's nutritional status triggering positive results on litter size of hyperprolific sows (e.g., more than 17 total born). However, body condition score must be carefully evaluated to prevent excessive weight gain during successive parities.

Chromium, CLA, and ractopamine for finishing pigs.

This study aimed to evaluate the effects of dietary chromium, CLA, and ractopamine on performance, carcass traits, and pork quality of finishing pigs slaughtered at 115 kg BW. Ninety-six crossbred barrows (initial BW = 70.21 ± 1.98 kg) were randomly assigned to 1 of 6 dietary treatments. There were 8 replicates per treatment (48 pens; 2 pigs/pen). A diet formulated according to the nutritional requirements was used as the control (CON). The other 5 diets were based on the CON and supplemented as follows: 0.4 mg/kg Cr yeast (CrY); 0.5% CLA; 0.4 mg/kg CrY and 0.5% CLA (CrY + CLA); 20 mg/kg ractopamine (RAC); 0.4 mg/kg CrY and 20 mg/kg RAC (CrY + RAC). Lysine levels on diets containing ractopamine were raised by 20% compared to CON to meet the greater requirements of pigs fed ractopamine. Pigs fed RAC and CrY + RAC were fed CON for the first 17 d, and then the respective diets for the last 28 d on trial. Data were analyzed in a model including the fixed effect of treatment (6 levels) and initial BW as a covariate for all characteristics, with the exception of carcass traits, in which final BW was used as a covariate. Least-squares means were separated using Tukey-Kramer's method. Differences were considered when probability values were lower than 0.05. Pigs fed RAC and CrY + RAC had the greatest ( < 0.001) final BW and ADG. Pigs fed CrY + RAC had greater ( < 0.001) G:F than pigs within the other groups, except for those fed RAC. Pigs fed CrY + RAC and RAC had similar G:F, both greater ( < 0.001) than pigs fed CON. Average daily feed intake was similar ( = 0.83) for all diets. Pigs fed CrY + RAC had greater LM area ( = 0.01) and carcass yield ( < 0.02) than pigs fed CON, CrY, CLA, and CrY + CLA. Loin muscle area and carcass yield of pigs fed RAC were not different from pigs fed the others diets. Pigs fed CON diets had greater BF ( = 0.02) than pigs fed CLA diet. Additives did not affect ( > 0.05) pork quality, except for color. No differences ( > 0.05) were observed for carcasses pH and temperature. The values for pigs fed RAC were greater ( = 0.01) than pigs fed other diets. Pigs fed RAC had lower ( < 0.01) values compared to pigs fed other experimental diets. Serum urea nitrogen concentration (SUN) was lower ( = 0.02) in pigs fed CrY + RAC than in pigs fed CON and RAC and similar to pigs fed the other feeding additives. In summary, it was demonstrated that, when combined, CrY and RAC increase LM area and carcass yield, and reduce SUN, suggesting that chromium could improve nutrient utilization by muscle cells in RAC-fed pigs. Additionally, the additives have no major effects on pork quality.

Nanoemulsions and nanoparticles for non-melanoma skin cancer: effects of lipid materials

Basal cell carcinomas and squamous cell carcinomas are non-melanoma skin cancers reported to be among the most common malignancies, being responsible for high human morbidity. Conventional chemotherapy applied to these conditions shows non-specific targeting, thus severe adverse side effects are also commonly reported. New therapeutic strategies based on nanoparticulates technology have emerged as alternatives for site specific chemotherapy. Among the different types of nanoparticulates, lipid nanoemulsions and nanoparticles have several advantages for topical delivery of poorly soluble chemotherapeutics. These particles show sustained drug release and protection of loaded drugs from chemical degradation. This technology is promising to enhance the intracellular concentration of drugs and consequently reduce the cytotoxicity of skin chemotherapy (AU)

Nanoemulsions and nanoparticles for non-melanoma skin cancer: effects of lipid materials.

Basal cell carcinomas and squamous cell carcinomas are non-melanoma skin cancers reported to be among the most common malignancies, being responsible for high human morbidity. Conventional chemotherapy applied to these conditions shows non-specific targeting, thus severe adverse side effects are also commonly reported. New therapeutic strategies based on nanoparticulates technology have emerged as alternatives for site specific chemotherapy. Among the different types of nanoparticulates, lipid nanoemulsions and nanoparticles have several advantages for topical delivery of poorly soluble chemotherapeutics. These particles show sustained drug release and protection of loaded drugs from chemical degradation. This technology is promising to enhance the intracellular concentration of drugs and consequently reduce the cytotoxicity of skin chemotherapy.

Thermo-sensitive gels containing lorazepam microspheres for intranasal brain targeting.

Thermo-sensitive gels containing lorazepam microspheres were developed and characterized for intranasal brain targeting. Pluronics (PF-127 and PF-68) have been selected since they are thermo-reversible polymers with the property of forming a solution at low temperatures (4-5 °C), and a gel at body temperature (37 °C). This property makes them an interesting material to work with, especially in case of controlled release formulations. The present study focuses on the development of an intranasal formulation for lorazepam, as an alternative route of drug delivery to the brain. Direct transport of drugs to the brain circumventing the brain barrier, following intranasal administration, provides a unique feature and better option to target brain. The presence of mucoadhesive microspheres in the gel vehicle via nasal route can achieve a dual purpose of prolonged drug release and enhanced bioavailability. To optimise the microsphere formulation, Box Behnken design was employed by investigating the effect of three factors, polymer concentration (chitosan), emulsifier concentration (Span 80) and cross-linking agent (glutaraldehyde) on the response variable which is the mean particle size. The concentration of 21% PF-127 and 1% PF-68 were found to be promising gel vehicles. The results showed that the release rate followed a prolonged profile dispersion of the microspheres in the viscous media, in comparison to the microspheres alone. Histopathological studies proved that the optimised formulation does not produce any toxic effect on the microscopic structure of nasal mucosa.